David Ricks
David Ricks is the Chief Executive Officer of Eli Lilly and Company, a leading pharmaceutical company known for its innovations in diabetes and weight loss medications, including Zepbound and Mounjaro. Under his leadership, the company announced a significant $27 billion investment to expand its manufacturing capabilities in the United States, aiming to bolster domestic production in response to potential tariffs and supply chain vulnerabilities exposed during the COVID-19 pandemic. Ricks has emphasized the importance of reshoring production and increasing manufacturing capacity to meet the growing demand for Eli Lilly's products.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
David Ricks believes that Giannis Skarimpas would appeal to English-speaking audiences who appreciate Beckett's prose.
8
United States:
Eli Lilly, led by David Ricks, is putting $27 billion into expanding domestic pharmaceutical production.
8
Ireland:
David Ricks is Eli Lilly’s chief executive who commented on the potential of the new weight-loss pill.
8
Ireland:
David Ricks, Eli Lilly’s chief executive, stated that orforglipron may provide a new option for weight management.
8
United Kingdom:
David Ricks, Eli Lilly’s chief executive, discussed the potential of orforglipron as a new option for weight management.
8
Denmark:
David Ricks, the CEO of Eli Lilly, stated that orforglipron could provide a new opportunity for people worldwide if approved.
9
Greece:
David Ricks, the CEO of Eli Lilly, referred to the new drug as a 'convenient solution, with one pill daily.'
8
United States:
David Ricks, CEO of Eli Lilly, announced plans to invest $27 billion to build four manufacturing plants in the US.
9
Vietnam:
David Ricks, CEO of Eli Lilly, expressed serious concerns about the impact of new tariffs on American businesses.
4
United Kingdom:
David Ricks, the boss of US pharmaceutical giant Eli Lilly, described the tariffs imposed by Donald Trump as a watershed moment in US economic history.
6